BACKGROUND: The clinical usefulness of [-2]pro-PSA (where PSA is prostate-specific antigen) in prostate cancer diagnosis has been emphasized in recent studies. To determine proper blood sample handling conditions for [-2]pro-PSA evaluation, we analyzed the preanalytical stability of [-2]pro-PSA. METHODS: Blood samples from 22 Japanese males were stored under various conditions before total PSA (tPSA), free PSA, and [-2]pro-PSA concentrations were measured, and the preanalytical stability of [-2]pro-PSA and the changes in the Prostate Health Index (phi) were assessed. RESULTS: [-2]Pro-PSA was stable in serum for at least 24 hr at both room temperature (RT) and at 4°C. However, [-2]pro-PSA levels in whole blood increased rapidly over time, particularly at RT. Mean recovery (%) of [-2]pro-PSA in whole blood at RT was >110% at 1 hr after drawing of blood. The phi tended to increase over time in a pattern similar to the change in[-2]pro-PSA. CONCLUSIONS: Preanalytical stability was lower for [-2]pro-PSA than for free PSA or tPSA. Whole-blood [-2]pro-PSA increased in a time-dependent manner, particularly at RT. Thus, whole blood samples collected at RT should be centrifuged within 1 hr after drawing. The [-2]pro-PSA in serum is stable for at least 24 hr at both RT and at 4°C.
BACKGROUND: The clinical usefulness of [-2]pro-PSA (where PSA is prostate-specific antigen) in prostate cancer diagnosis has been emphasized in recent studies. To determine proper blood sample handling conditions for [-2]pro-PSA evaluation, we analyzed the preanalytical stability of [-2]pro-PSA. METHODS: Blood samples from 22 Japanese males were stored under various conditions before total PSA (tPSA), free PSA, and [-2]pro-PSA concentrations were measured, and the preanalytical stability of [-2]pro-PSA and the changes in the Prostate Health Index (phi) were assessed. RESULTS: [-2]Pro-PSA was stable in serum for at least 24 hr at both room temperature (RT) and at 4°C. However, [-2]pro-PSA levels in whole blood increased rapidly over time, particularly at RT. Mean recovery (%) of [-2]pro-PSA in whole blood at RT was >110% at 1 hr after drawing of blood. The phi tended to increase over time in a pattern similar to the change in[-2]pro-PSA. CONCLUSIONS: Preanalytical stability was lower for [-2]pro-PSA than for free PSA or tPSA. Whole-blood [-2]pro-PSA increased in a time-dependent manner, particularly at RT. Thus, whole blood samples collected at RT should be centrifuged within 1 hr after drawing. The [-2]pro-PSA in serum is stable for at least 24 hr at both RT and at 4°C.
Authors: Ake Lundwall; Vimla Band; Michael Blaber; Judith A Clements; Yves Courty; Eleftherios P Diamandis; Hans Fritz; Hans Lilja; Johan Malm; Lois J Maltais; A Yvonne Olsson; Constantina Petraki; Andreas Scorilas; Georgia Sotiropoulou; Ulf-Håkan Stenman; Carsten Stephan; Maroulio Talieri; George M Yousef Journal: Biol Chem Date: 2006-06 Impact factor: 3.915
Authors: Lori J Sokoll; Daniel W Chan; Stephen D Mikolajczyk; Harry G Rittenhouse; Cindy L Evans; Harry J Linton; Leslie A Mangold; Phaedre Mohr; Georg Bartsch; Helmut Klocker; Wolfgang Horninger; Alan W Partin Journal: Urology Date: 2003-02 Impact factor: 2.649
Authors: Masood A Khan; Alan W Partin; Harry G Rittenhouse; Stephen D Mikolajczyk; Lori J Sokoll; Daniel W Chan; Robert W Veltri Journal: J Urol Date: 2003-09 Impact factor: 7.450
Authors: Iacovos P Michael; Georgios Pampalakis; Stephen D Mikolajczyk; Johan Malm; Georgia Sotiropoulou; Eleftherios P Diamandis Journal: J Biol Chem Date: 2006-03-03 Impact factor: 5.157
Authors: Shea P O'Connell; Maria Frantzi; Agnieszka Latosinska; Martyn Webb; William Mullen; Martin Pejchinovski; Mark Salji; Harald Mischak; Colin S Cooper; Jeremy Clark; Daniel S Brewer Journal: Cancers (Basel) Date: 2022-04-14 Impact factor: 6.575